What is BioDistrict New Orleans?
BioDistrict New Orleans, officially called The Greater New Orleans Biosciences Economic Development District, is a state agency that was created by Act No. 487 of the Louisiana State Legislature in the 2005 regular session.
Where is the BioDistrict located?
The BioDistrict comprises 1,500 acres spanning the Downtown and Mid-City neighborhoods of New Orleans. The BioDistrict is bounded by Earhart Boulevard, Carrollton Avenue, Loyola Avenue and Iberville Street.
What is the vision of BioDistrict New Orleans?
The vision of the BioDistrict is to build a globally competitive economy for the New Orleans region to diversify our opportunities and build a community through innovation that contains the healthiest, safest, smartest and most sustainable neighborhoods in America.
What is the mission of BioDistrict New Orleans?
As derived from the enabling legislation of Act No. 487 of the Louisiana House of Representatives Session of 2005, the mission of the BioDistrict includes:
- Facilitating the creation of high-paying jobs in the region by increasing the current health and biosciences workforce
- Growing the academic research institutions in the region by increasing investment in clinical, biosciences, and health-related research and training
- Enhancing interdisciplinary collaboration among the biosciences by locating key research institutions and private sector biosciences companies within a designated biosciences district.
What exactly is “bioscience”?
Bioscience, or life science, can be defined as an ever-evolving interplay of biology, health and technology in research, innovation and commercialization. It involves not only medical enterprises, but also biotechnology and environmental research for sustainability.
What are the major building blocks of building a biosciences industry?
To create and sustain a biosciences industry specific to the New Orleans region, the BioDistrict must focus on:
- Workforce Development
- Education and the Sciences
- Specialized Facilities
- Public Policy
- Business Community
- Convention Industry
- Capital Formation
What are some of the new catalytic projects in the BioDistrict?
Some of the most exciting developing projects in the BioDistrict include the new Veterans Affairs Hospital, the new University Medical Center, Louisiana Cancer Research Center, and the New Orleans BioInnovation Center. Other exciting improvements in the District include Champions Square at the Louisiana Superdome, Benson Tower, and the renovation of the Hyatt hotel. The BioDistrict’s existing cornerstone educational facilities include Xavier University of Louisiana, LSU Health Sciences Center, Tulane University Medical Center, Delgado Community College, and Dillard University.
What is the BioDistrict doing in its master planning process?
The BioDistrict is currently engaged in a four-phase, 14-month master planning process. The master planning team consists of AECOM, CB Richard Ellis, Cannon Design, Chester Engineering, The Ehrhardt Group and Bright Moments. Working Papers and other deliverables produced for the BioDistrict New Orleans Master Plan can be viewed in the Resources page.
What is the difference between GNOBEDD (The Greater New Orleans Biosciences Economic Development District) and BioDistrict New Orleans?
No difference at all—we are one and the same. The state agency now refers to itself as “BioDistrict New Orleans” for ease of use and immediate recognition of the area and the mission of the District.
Who is the BioDistrict New Orleans team?
BioDistrict New Orleans is made up of a dedicated full-time staff, as well as a 12-member Board of Commissiners, all currently fully seated. Board members include representatives from each of the major academic and medical institutions, including Xavier University, Delgado Community College, Louisiana State University, Tulane University, and Ochsner Health System. The Board also includes four appointments from the Governor of Louisiana and one from the Department of Louisiana Economic Development (LED). In addition, the Mayor of New Orleans also has four appointments representing individuals from GNO, Inc., the New Orleans Business Council, the New Orleans Chamber of Commerce, and a seat for the Mayor at Large, currently filled by Deputy Mayor of New Orleans, Andrew Kopplin. James McNamara is the BioDistrict President and CEO. For staff listing and contact information, please click on Contact.
What are the bioscience and biomed workforce trends and training opportunities in the Greater New Orleans area?
A gap surplus analysis of the bioscience and biomedical workforce in New Orleans was commissioned by the New Orleans BioInnovation Center on behalf of the BioDistrict in October 2009. The study was funded by a grant from the Baptist Community Ministries foundation. The final report will not be available in April 2011, but the preliminary analysis of existing workforce data conducted by Research Edge can be viewed in here.
What are the projected economic impacts of the BioDistrict?
Consultants from GCR & Associates, Inc. have conducted research and prepared reports on the demographic and economic baseline of the BioDistrict in 2010 and the BioDistrict’s projected economic impact in terms of direct and indirect job creation as well as tax revenue.
The purpose of these Demographic And Economic Baseline Report is two-fold. First, it provides the BioDistrict and its partners with credible indicators of current demographic and economic data with which to analyze public and private investment opportunities, programmatic initiatives, and market potential. Secondly, is serves as a benchmark to measure the ongoing impact of the growth of the biosciences industry on the District’s population, demographic composition, economic competitiveness, and real estate dynamics. Five, ten, or twenty years down the road, the most cogent and concise way to analyze the effects of the BioDistrict’s efforts will be to compare those future conditions to the 2010 starting point.
The primary purpose of the Economic Impact Study is to present the substantial job creation and tax revenue which will result directly from current development within the BioDistrict (LCRC, VA, UMC). The secondary purpose is to compare local developments to existing bioscience and medical research clusters throughout the nation and thereby illustrate the growth of medical research as a major industry within a local community and the economic importance of the industry to the community.